An uncommon presentation of stroke in a child with trisomy 21

Pediatric Emergency Care

Volumn 24, Issue 4, 2008, Pages 230-232

  Boggs, Sarah ^a   Hariharan, Selena L ^a  

^a CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

Author keywords

Moyamoya; Stroke; Trisomy 21

Indexed keywords

C REACTIVE PROTEIN;

ANAMNESIS; ARTICLE; BRAIN DISEASE; BRAIN INFARCTION; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; DOWN SYNDROME; FEVER; HEMIPARESIS; HUMAN; LABORATORY TEST; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MOYAMOYA DISEASE; NEWBORN INTENSIVE CARE; PHYSICAL EXAMINATION; PRESCHOOL CHILD; RARE DISEASE; STROKE; TRISOMY 21; WEIGHT BEARING;

CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DOWN SYNDROME; HUMANS; MALE; MOYAMOYA DISEASE; STROKE;

EID: 42449157664     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/PEC.0b013e31816b7a7b     Document Type: Article

References (17)

1. Calder K, Kokorowski P, Tran T, et al. Emergency department presentation of pediatric stroke. Pediatr Emerg Care. 2003;19:320-328.
2. Gabis LV, Yangala R, Lenn NJ. Time lag to diagnosis of stroke in children. Pediatrics. 2002;110:924-928.
3. Braun KP, Kappelle LJ, Kirkham FJ, et al. Diagnostic pitfalls in paediatric ischaemic stroke. Dev Med Child Neurol. 2006;48:985-990.
4. Cheng WW, Ko CH, Chan AK. Paediatric stroke: case series. Hong Kong Med J. 2002;8:216-220.
5. Fiebach JB, Schellinger PD, Jansen O, et al. CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke. 2002;33:2206-2210.
6. Ganesan V, Prengler M, McShane MA, et al. Investigation of risk factor in children with arterial ischemic stroke. Ann Neurol. 2003;53:167-173.
7. Fung CW, Kwang KL, Tsui EYK, et al. Moyamoya in a child with Down syndrome. Hong Kong Med J. 2003;9:63-66.
8. Yamamoto LG, Yim GK, Bart RD. Emergency department presentations of cerebrovascular disease in children. Am J Emerg Med. 1999;17:163-171.
9. Chiu D, Shedden P, Bratina P, et al. Clinical features of moyamoya disease in the United States. Stroke. 1998;29:1347-1351.
10. Cramer SC, Robertson RL, Dooling EC, et al. Moyamoya and Down syndrome: clinical and radiological features. Stroke. 1996;27:2131-2135.
11. Vicari S, Albertini G. Moyamoya disease in Down's syndrome: a report of two cases. J Ment Defic Res. 1991;35:392-397.
12. Gosalakkal JA. Moyamoya disease: a review. Neurol India. 2002;50:6-10.
13. Yamamoto M, Aoyagi M, Tajima S, et al. Increase in elastin gene expression and protein synthesis in arterial smooth muscle cells derived from patients with moyamoya disease. Stroke. 1997;28:1733-1738.
14. Yamamoto M, Aoyagi M, Fukai N, et al. Increase in prostaglandin E(2) production by interleukin-1 beta in arterial smooth muscle cells derived from patients with moyamoya disease. Circ Res. 1999;29:1347-1351.
15. DeBorchgrave V, Saussu F, Depre A, et al. Moyamoya and Down syndrome: case report and review of the literature. Acta Neurol Belg. 2002;102:63-66.
16. Ikezaki K. Rational approach to the treatment of moyamoya disease in childhood. J Child Neurol. 2000;15:350-356.
17. Fung LW, Thompson D, Ganesan V. Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst. 2005;21:358-364.